ロード中...
Methotrexate in Rheumatoid Arthritis: A Quarter Century of Development
Methotrexate (MTX) is now the most popular drug worldwide for the treatment of rheumatoid arthritis. Low-dose, weekly MTX (10 to 25 mg/wk) used as either monotherapy or in combination with other drugs has a superior efficacy profile as defined in placebo-controlled trials and comparable efficacy to...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Clinical and Climatological Association
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3715949/ https://ncbi.nlm.nih.gov/pubmed/23874006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|